Table 2.
Pre-pandemic cohort, n=29 | CD4+ T cell Reactivity | % CD4+ Reactivity | CD8+ T cell Reactivity | % CD8 Reactivity |
| ||||
CD4_Non-spike | 13 | 44.8% | 5 | 17.2% |
|
||||
CD4_Spike | 17 | 58.6% | 9 | 31.0% |
|
||||
CD8_A | 9 | 31.0% | 6 | 20.7% |
|
||||
CD8_B | 12 | 41.4% | 8 | 27.6% |
|
||||
|
||||
Total Pools Reactive | ||||
|
||||
0 | 8 | 27.6% | 10 | 34.5% |
|
||||
1 | 6 | 20.7% | 9 | 31.0% |
|
||||
2 | 5 | 17.2% | 5 | 17.2% |
|
||||
3 | 5 | 17.2% | 3 | 10.3% |
|
||||
4 | 5 | 17.2% | 0 | 0.0% |
|
||||
|
||||
No Reactive T cells | CD4+ T Cell reactive only | CD8+ T cells reactive only | Both T cells reactive | |
|
||||
# of participants | 3 | 9 | 4 | 13 |
|
||||
% of participant | 10.3% | 31.0% | 13.8% | 44.8% |
|